Literature DB >> 24501328

Myocyte signalling in leucocyte recruitment to the heart.

Alessandra Ghigo1, Irene Franco, Fulvio Morello, Emilio Hirsch.   

Abstract

Myocardial damage, by different noxious causes, triggers an inflammatory reaction driving post-injury repair mechanisms and chronic remodelling processes that are largely detrimental to cardiac function. Cardiomyocytes have recently emerged as key players in orchestrating this inflammatory response. Injured cardiomyocytes release damage-associated molecular pattern molecules, such as high-mobility group box 1 (HMGB1), DNA fragments, heat shock proteins, and matricellular proteins, which instruct surrounding healthy cadiomyocytes to produce inflammatory mediators. These mediators, mainly interleukin (IL)-1β, IL-6, macrophage chemoattractant protein (MCP)-1, and tumour necrosis factor α (TNF-α), in turn activate versatile signalling networks within surviving cardiomyocytes and trigger leucocyte activation and recruitment. In this review, we will focus on recently characterized signalling pathways activated in cardiomyocytes that mediate inflammatory responses during myocardial infarction, hypertensive heart disease, and myocarditis.

Entities:  

Keywords:  Cardiac inflammation; Cytokines; Heart disease; Leucocyte recruitment; Signalling pathways

Mesh:

Substances:

Year:  2014        PMID: 24501328     DOI: 10.1093/cvr/cvu030

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  26 in total

1.  Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling.

Authors:  Takeshi Suetomi; Andrew Willeford; Cameron S Brand; Yoshitake Cho; Robert S Ross; Shigeki Miyamoto; Joan Heller Brown
Journal:  Circulation       Date:  2018-11-27       Impact factor: 29.690

2.  Stressed hearts inflame the body (in a good way).

Authors:  Toru Hashimoto; David A Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-21       Impact factor: 11.205

3.  CaMKIIδ-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis.

Authors:  Andrew Willeford; Takeshi Suetomi; Audrey Nickle; Hal M Hoffman; Shigeki Miyamoto; Joan Heller Brown
Journal:  JCI Insight       Date:  2018-06-21

4.  Gender disparity in the role of TLR2 in post-ischemic myocardial inflammation and injury.

Authors:  Jilin Li; Lihua Ao; Yufeng Zhai; Joseph C Jr Cleveland; David A Fullerton; Xianzhong Meng
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  Hypoxia drives cardiac miRNAs and inflammation in the right and left ventricle.

Authors:  Philippe Chouvarine; Ekaterina Legchenko; Jonas Geldner; Christian Riehle; Georg Hansmann
Journal:  J Mol Med (Berl)       Date:  2019-07-23       Impact factor: 4.599

6.  The contribution of the cardiomyocyte to tissue inflammation in cardiomyopathies.

Authors:  Van Kim Ninh; Joan Heller Brown
Journal:  Curr Opin Physiol       Date:  2020-10-14

7.  Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function.

Authors:  Deanna K Sosnowski; K Lockhart Jamieson; Artiom Gruzdev; Yingxi Li; Robert Valencia; Ala Yousef; Zamaneh Kassiri; Darryl C Zeldin; John M Seubert
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-08-19       Impact factor: 5.125

Review 8.  The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.

Authors:  Sumanth D Prabhu; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

Review 9.  Chemokines in Myocardial Infarction.

Authors:  Bijun Chen; Nikolaos G Frangogiannis
Journal:  J Cardiovasc Transl Res       Date:  2020-05-15       Impact factor: 4.132

10.  Reg-ulating macrophage infiltration to alter wound healing following myocardial infarction.

Authors:  Merry L Lindsey
Journal:  Cardiovasc Res       Date:  2018-10-01       Impact factor: 13.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.